Table 2.
MALT sample characteristics, comparing between approached, not approached, and consented groups.
| Characteristics | Approached, Not Consented | Not Approached | Consented | Total | P value |
|---|---|---|---|---|---|
| All Eligible Participants | 21 (100.0%) | 238 (100.0%) | 400 (100.0%) | 659 (100.0%) | |
| Primary diagnosis | |||||
| Missing | 0 | 3 (1.3%) | 0 | 3 (0.5%) | 0.8667 |
| Biliary Atresia | 10 (47.6%) | 110 (46.2%) | 193 (48.3%) | 313 (47.5%) | |
| Other Cholestatic | 2 (9.5%) | 19 (8.0%) | 35 (8.8%) | 56 (8.5%) | |
| Acute L. Failure | 5 (23.8%) | 24 (10.1%) | 41 (10.3%) | 70 (10.6%) | |
| Metabolic | 3 (14.3%) | 36 (15.1%) | 60 (15.0%) | 99 (15.0%) | |
| Tumor | 0 | 19 (8.0%) | 34 (8.5%) | 53 (8.0%) | |
| AIH | 0 | 2 (0.8%) | 3 (0.8%) | 5 (0.8%) | |
| Other | 1 (4.8%) | 25 (10.5%) | 34 (8.5%) | 60 (9.1%) | |
| Age at transplant (years) | |||||
| N | 21 | 238 | 400 | 659 | 0.0147 |
| Mean (SD) | 3.2 (3.8) | 2.5 (3.3) | 2.9 (3.4) | 2.7 (3.4) | |
| Median (Min, Max) | 2.5 (0.0, 13.0) | 1.0 (0.0, 16.0) | 1.3 (0.0, 15.8) | 1.2 (0.0, 16.0) | |
| Gender | |||||
| Male | 11 (52.4%) | 116 (48.7%) | 189 (47.3%) | 316 (48.0%) | 0.8593 |
| Female | 10 (47.6%) | 122 (51.3%) | 211 (52.8%) | 343 (52.0%) | |
| Race | |||||
| American Indian or Alaska Native | 0 | 0 | 1 (0.3%) | 1 (0.2%) | 0.1362 |
| Asian | 3 (14.3%) | 6 (2.5%) | 25 (6.3%) | 34 (5.2%) | |
| Black or African American | 4 (19.0%) | 24 (10.1%) | 56 (14.0%) | 84 (12.7%) | |
| Native Hawaiian or Pacific Islander | 0 | 0 | 2 (0.5%) | 2 (0.3%) | |
| White or Caucasian | 9 (42.9%) | 174 (73.1%) | 268 (67.0%) | 451 (68.4%) | |
| Other | 4 (19.0%) | 19 (8.0%) | 25 (6.3%) | 48 (7.3%) | |
| More than one race | 0 | 2 (0.8%) | 3 (0.8%) | 5 (0.8%) | |
| Not reported | 1 (4.8%) | 13 (5.5%) | 20 (5.0%) | 34 (5.2%) | |